Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
NASDAQ:CBLL
CBLL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$18.69 - $32.75
Previous CloseN/A
Volume46.56K
Average Volume (3M)201.01K
Market Cap
$796.64M
Enterprise ValueN/A
Total Cash (Recent Filing)$194.37M
Total Debt (Recent Filing)$21.96M
Price to Earnings (P/E)―
Beta1.69
Next Earnings
Nov 18, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding35,868,340
10 Day Avg. Volume301,118
30 Day Avg. Volume201,012
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$33.67Price Target Upside48.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
Ceribell, Inc. News
PremiumCompany Announcements
CeriBell’s Earnings Call: Strong Growth Amid Challenges
PremiumCompany Announcements
Ceribell, Inc. Reports Strong 2024 Financial Growth---
Bulls Say, Bears Say
Bulls Say
Future GuidanceManagement issued prudent FY25 guidance, projecting significant revenue growth, aligning with analyst estimates.
Revenue PerformanceCeribell reported Q4/24 revenue of $18.5M, beating both the estimate and consensus.
Bears Say
Regulatory ChallengesCeribell has submitted for 510(k) approval for the pediatric indication, showing progress in regulatory milestones.
---
Ownership Overview
24.33% Insiders
12.59% Mutual Funds
36.50% Other Institutional Investors
23.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $18.69 and its highest was $32.75 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $796.64M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 252 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on Feb 25, 2025. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.318 by -$0.082.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate is -0.32.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 35,868,340 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.318. Following the earnings report the stock price went down -1.331%.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
---
Ceribell, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.67 (48.39% Upside)
$33.67 (48.39% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $6.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Company Description
Ceribell, Inc.
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.
---
CBLL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
CeriBell demonstrated strong revenue growth and maintained high gross margins, successfully expanded its account base, and completed a successful IPO. However, increased operating expenses, a higher net loss, and tariffs on materials from China are notable challenges. Overall, the highlights outweigh the lowlights, indicating a positive sentiment for the earnings call.Read More>---
CBLL Stock 12 Month Forecast
Average Price Target
$33.67
▲(48.39% Upside)
Technical Analysis
Best Analysts Covering CBLL
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-18.87%
reiterated a buy rating 15 days ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.87% per trade.
---